First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totaling 35,295 shares, an increase of 79.8% from the April 15th total of 19,633 shares. Based on an average daily trading volume, of 53,486 shares, the short-interest ratio is currently 0.7 days. Currently, 0.3% of the shares of the company are short sold.
Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund
Hedge funds have recently made changes to their positions in the business. High Point Wealth Management LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at approximately $26,000. AG Campbell Advisory LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at approximately $31,000. Russell Investments Group Ltd. lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after buying an additional 158 shares during the last quarter. Rossby Financial LCC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 160.0% in the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock valued at $31,000 after buying an additional 104 shares during the last quarter. Finally, Cassaday & Co Wealth Management LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the first quarter valued at approximately $34,000.
First Trust NYSE Arca Biotechnology Index Fund Price Performance
FBT opened at $206.89 on Monday. First Trust NYSE Arca Biotechnology Index Fund has a 12-month low of $156.63 and a 12-month high of $224.94. The stock has a market cap of $2.34 billion, a price-to-earnings ratio of 21.72 and a beta of 0.66. The business has a 50 day moving average of $202.28 and a 200-day moving average of $206.34.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
